VCU/HHMI Summer Scholars program

Slides:



Advertisements
Similar presentations
Supplemental Figure 1 actin MocksiRNA1siRNA2Mock Li Fraumeni (087)5C tankyrase1 100
Advertisements

Possible Link between Cancer Multidrug Resistance and Epigenetics Erin Wildeman, Marcos Pires, PhD Lehigh University Department of Chemistry, Bethlehem,
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
Modulation of the Cellular Phenotype in Human Colon Adenocarcinoma Cells by Folic Acid and Polyamine Pools Nathan W. Sweeney, Julie A. Buckmeier, Christina.
Functional consequences of NLS mutations in human MLH1 Alex Dukes Dr. Andrew Buermeyer Department of Environmental & Molecular Toxicology Oregon State.
Effects of Etoposide on the Apoptosis of HL-60 Cells Stefanos F. Haddad a, Glaucia V. Faheina-Martins b,c, Demetrius A. M. Araújo b,c a Department of Biology,
Introduction and Background Abstract Our research is directed towards determining which treatments for cancer are the most effective on a cellular level.
Enhancing the C-48 STAT3 Inhibitor
Characterization of a potential new drug in cancer therapy Lab 2 Salah Farag.
Understanding patent claims (f) Drug for the treatment of cancer.
Supplementary Fig. 1. (a) Cells were treated with DMSO or with 1 µM of SK-7068 or LAQ824 for 18 hours. They were then fixed with 70% ethanol, stained with.
Figure S1 A MRC5 Control Chk1 TdR(h): γH2AX Cleaved casp3 RPA34
Cancer Chemotherapy Topics
Chemotherapy of Medulloblastoma By: Minh Trinh. Objectives Briefly describe chemotherapy of medulloblastoma Discuss different regimens used for therapy.
Cancer therapy - conventional Surgery Radiotherapy Chemotherapy Adjuvant therapies.
Cancer Drug Classes The classes of drugs currently used in the cancer clinic are  1. DNA Binding Agents (intercalating and alkylating.
ANTINEOPLASTICS I: GENERAL CONCEPTS
Bleomycin Catalina Cuervo. Outline of Topics Introduction to Bleomycin Structure Mechanism Resistance Analogs Conclusion.
Nanocell: Mechanism of action
 Dr. Steven Grant  Dr. Roberto Rosato  Jorge Almenara  Stefanie Coe  Dr. Allison Johnson, HHMI Coordinator.
Table S1. Hypoxia increases signaling through JNK in colon cancer cell lines in a cell-specific manner Shown are the ratios of c-Jun phosphorylation during.
Colin Tominey Dr. John Hays Oregon State University 25 September 2009 The Effect of ATR and ATM on UVB-Induced Stem and Progenitor Cell Death in Arabidopsis.
Heat Shock Protein 90 (HSP90) is over-expressed in p16 negative oropharyngeal squamous cell carcinoma and its inhibition in vitro potentiates the effects.
Cytotoxic Drugs. III Dr. Yieldez Bassiouni.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 20 Antineoplastic.
HDAC6 : HDAC6 is a cytoplasmic enzyme that regulates many important biological processes. : HDAC6 has recently emerged as a tubulin deacetylase that has.
Inhibition of PDCD6 Induces Cell Proliferation and Reduces Apoptosis in Human Epithelial Ovarian Cancer Cells Yan Huang, Xiaohua Wu Department of Gynecology,
Cell Suicide in Health and Disease
Effects of metformin and thymoquinone on survival of leukemic cells
An investigation into the role of Akt3 in drug resistance Ramey Elsarrag.
Introduction Results References Active nuclear transport is disrupted before nuclear envelope breakdown during chemotherapy induced apoptosis in HeLa cells.
Role of the p21 Protein in the Fanconi Anemia (FA) Pathway
Paige Myers & Mahek Shah.  Cancer is a disease in which the DNA of cells becomes damaged or changed and the affected cells do not respond to apoptosis.
Targeting of reactive oxygen species can be a potential therapeutic strategy for cancer treatment Ying-Ray Lee 1, San-Yuan Chen 2, and Hau-Ren Chen 3 1.
Glutamate transporter SLC1A1 is dysregulated in SN38- and Oxaliplatin-resistant colorectal cancer cells Elena Pedraz-Cuesta 1, Sandra Christensen 1, Anders.
Chemotherapy : Drug resistance Gabriela M. Almeida Cancer Biology Group IPATIMUP Encontro Ciência 2010 Lisboa, 4 Junho 2010 ChemotherapyRecurrence Drug.
Investigation of the effect of Thymoquinone (TQ) alone or in combination with cisplatin on cell growth, cell cycle progression and apoptosis of human oral.
5. ROLE OF METALS IN MEDICINE. There are an astonishing number and variety of roles that metals play in contemporary medicine.
Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines Xueqing Wang China JST hospital.
Elucidate the mechanism of anticancer activity of Piper nigrum extract on colon cancer cell line Akila Prashant, MVSST Subbarao, Devananda D, Prashant.
Results and Discussion
Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model  Jie Li, Ni Hou, Ahmad Faried, Soichi Tsutsumi,
Figure 5. FK866 caused apoptosis in MCF-7 cells while nicotinamide adenine dinucleotide (NAD+) reversed FK866-induced apoptosis. (A) Representative quadrant.
DNA content flow cytometric histograms of propidium iodide–stained A549 cells. DNA content flow cytometric histograms of propidium iodide–stained A549.
by Kirsteen H. Maclean, John L. Cleveland, and John B. Porter
Volume 4, Issue 1, Pages (July 2001)
Volume 19, Issue 10, Pages (October 2017)
Supplemental Figure 1 Li Fraumeni (087) 5C tankyrase1 actin Mock
SUPPLEMENTAL TABLE 1. Cell cycle profiles of HeLa cells treated
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer  Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells  Sebastian Kobold,
A novel class I histone deacetylase inhibitor, I-7ab,
FLC treatment results in an increase in ploidy in a significant fraction of cells. FLC treatment results in an increase in ploidy in a significant fraction.
Palbociclib increases proteasome activity and the clearance of protein aggregates without significant effects on autophagy Palbociclib increases proteasome.
Effect of expression of constitutively active CAMKK2 on AMPK activation and the cell cycle in G361 cells. Effect of expression of constitutively active.
Volume 18, Issue 12, Pages (December 2010)
Lapatinib reduces IGF-I signaling in trastuzumab-resistant cells.
Fig. 5. Combination of SAHA and ML produces augmented suppression of cellular proliferation with impaired cell cycle progression, enhanced apoptotic.
CD40 Ligation Alters the Cell Cycle of Differentiating Keratinocytes
Induction of apoptosis by NS398.
Protracted temozolomide (TMZ) treatment leads to acquired TMZ resistance in glioblastoma (GBM) cells in vivo. Protracted temozolomide (TMZ) treatment leads.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
OBJECTIVES To learn the mechanism of cytotoxicity and toxicity of the commonly used antimetabolites.
Increased apoptotic levels after combined treatment with vincristine (VCR) and imatinib. Increased apoptotic levels after combined treatment with vincristine.
Increased apoptotic levels after combined treatment with DXR and imatinib. Increased apoptotic levels after combined treatment with DXR and imatinib. A–D.
Sorafenib inhibits cell proliferation and induces apoptosis in HCC cells. Sorafenib inhibits cell proliferation and induces apoptosis in HCC cells. A,
Quercetin induces autophagy, blocks cell cycle and activation of ERK and JNK signaling pathways participates in the G1 arrest in P39 cells. Quercetin induces.
ARQ 531 is cytotoxic to CLL cells, decreases NF-κB function, and inhibits migration. ARQ 531 is cytotoxic to CLL cells, decreases NF-κB function, and inhibits.
WEE1 inhibition followed by TRAIL treatment results in apoptotic cell death in MB231 cells. WEE1 inhibition followed by TRAIL treatment results in apoptotic.
Mohammed Charbat.
Presentation transcript:

VCU/HHMI Summer Scholars program IS PLATINUM-BASED DRUG CYTOTOXICITY ENHANCED BY THE ANTIDEPRESSANT DESIPRAMINE? Sandeep Sharma VCU/HHMI Summer Scholars program Mentor: Dr J.J. Ryan Department of Biology

Hypothesis Since resistance to chemotherapeutic drugs is frequently associated with reduced drug uptake, increasing drug uptake can enhance cell killing. Some anti-depressants can alter the function of transport proteins that allow cells to accumulate drugs. We postulated that the anti-depressant desipramine could enhance cell killing by platinum-based chemotherapy.

The two major experiments carried out were: The Effect of Desipramine on cisplatin (c DDP)-mediated killing of A2780 ovarian carcinoma cells. Effect of Desipramine on Oxaliplatin + 5FU- Mediated killing of HCT116 colorectal carcinoma cells.

Cis-diamminedichloroplatinum(II) c DDP Background Cis-diamminedichloroplatinum(II) c DDP A platinum based chemotherapy drug used to treat several types of cancer such as sarcomas, lyphomas and ovarian cancer. It was the first member of its class which also includes carboplatin and oxaliplatin. The cytoxoxicity is mainly through the interactions with DNA and the inhibtion of synthesis and replication by formation of interstrand and intrastrand cross links.

Oxaliplatin Is a platinum based chemotherapy drug. Typically is administered with fluorouracil and leucovorin for the treatment of colorectal cancer. It has a similar structure to cisplatin where the two amine groups are replaced by cyclohexyl diamine and the chlorine ligands are replaced by the oxalato-bidentate.

Fluorouracil 5-FU Belongs to the family of drugs called antimetabolites. It acts prinicipally as a thymidylate synthase inhibitor, interrupting an enzyme that is critical factor in the synthesis of pyrimidine which is important in DNA replication.

Desipramine Desipramine- A tricyclic antidepressant. Its activity rises from inhibiting reuptake and in the process raising the level of seretonin and norepinephrin in the synaptic cleft. It is also used for treating neuropathic pain especially with prostate cancer patients. Desipramine can block organic ion transporters (OCTs), and hence may alter drug uptake.

PROTOCOL Tryposonized and collected HCT 116 cells and A2780 cells. Aliqouted 150,00 cells into 3mL cRPMI(media) in 6 well plates. Added the different drugs according to the different culture conditions. Cultured the cells for 72 hours. Collected adherent and non-adherent cells. Fixed the cells in ethanol. Performed PI-DNA staining. Analysed the cells for DNA content on a FACScan/FACSCalibur flow cytometer.

PI DNA STAINING ASSAY Treatment with Drug Fixed overnight Cells Stained with propidium iodide Analyzed by Flow Cytometry Cell Cycle

Desipramine Augments c DDP Induced Killing

Cell Killing with Desipramine is Better than Oxaliplatin and 5FU Alone

Conclusions Desipramine augments killing of both ovarian and colorectal carcinoma cells. Other studies from our lab recently showed that desipramine has little or no effect on drug uptake, but enhances the activation of apoptotic pathways, including p53. Because desipramine is approved for clinical use, it may be an excellent means to augment standard chemotherapeutic treatment.

Acknowledgements Dr. Ryan for his tremendous support and guidance. All members of the Ryan lab for all their help and encouragement: Peyman Kabolizadeh Brian Barnstein Sarah Kennedy Jenifer Brenzovich Kevin Dholaria Dr. Buck and Dr. Johnson.